WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA ...

Zimmer Biomet Holdings, Inc. has a 52 week low of $97.69 and a 52 week high of $133.90. The company has a current ratio of 1.91, a quick ratio of 0.70 and a debt-to-equity ratio of 0.43.

WARSAW, Ind., Feb. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced upcoming changes to the Company's Board of ...

In the third quarter of 2024, Zimmer Biomet reported sales of $1.82 billion, representing an approximate 4% year-over-year growth and aligning with consensus estimates. The company's adjusted ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has announced the issuance of a series of new notes totaling $1.75 billion on Wednesday. The medical device company, currently trading near its 52-week low ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, has entered into a strategic distribution agreement with Promamec, a leading provider of medical devices in ...

WARSAW, Ind., Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the ...

Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare solutions with a market cap of $19.7 billion. Headquartered in Warsaw ...

Zimmer Biomet Holdings, Inc. has a 1-year low of $97.69 and a 1-year high of $133.90. Zimmer Biomet ( NYSE:ZBH – Get Free Report ) last posted its earnings results on Thursday, February 6th.

Legendary composer Hans Zimmer is explaining why he decided to press skip on scoring any Marvel film soundtracks. During a recent visit to the Happy Sad Confused podcast, host Josh Horowitz ...